Pars Roos

Pars Roos is a prominent Iranian pharmaceutical company dedicated to the research, development, and large-scale manufacturing of advanced therapeutic products. The company specializes in the production of high-value medicines, including recombinant proteins, peptides, and complex small molecules. Their product portfolio primarily addresses critical health needs in endocrinology, oncology, and metabolic disorders, with a notable focus on insulin analogs and bone health treatments. Pars Roos maintains state-of-the-art manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards to ensure the quality and safety of its diverse pharmaceutical offerings. The firm plays a significant role in the regional supply chain by providing affordable biosimilars and essential medicines to the Middle Eastern market.